日本人口中癌症的遗传性:根据最近的队列数据进行估计
Yoshiro Nagao1,2, Kei Takeshita1
1Department of Clinical Genetics, Tokai University Hospital, Isehara, Kanagawa, Japan.
Clinical genetics
|April 30, 2024
概括
这项研究估计了日本人口的癌症遗传性,发现整体遗传性 (h2) 为0.064. 这些遗传见解对于理解癌症遗传学和为遗传咨询提供信息至关重要.
科学领域:
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
- 流行病学 流行病学
背景情况:
- 癌症通常是多因素疾病,受遗传和环境因素的影响.
- 遗传性 (h2) 量化了遗传因素对疾病风险的贡献.
- 估计癌症遗传性对于理解遗传倾向至关重要,但报告很少.
研究的目的:
- 在日本人口中估计整体和特定癌症的遗传性.
- 为了比较日本和其他族群之间的癌症遗传概率估计.
- 为癌症遗传学和遗传咨询提供见解.
主要方法:
- 利用来自大型前性队列研究的数据 (Hidaka等, 2020).
- 使用人口发病率和一级亲属的家族复发率计算遗传性 (h2).
- 专注于整体癌症和特定类型,包括胃癌,结直肠癌,肺癌和子宫癌.
主要成果:
- 在日本人群中,总体癌症遗传率估计为0.064,明显低于北欧人群 (0.33).
- 个人癌症遗传概率估计 (胃:0.14,结肠直肠:0.006,肺:0.08,子宫:0.16) 通常低于欧洲血统报告的估计.
- 这些发现代表了日本人口中癌症的第一个遗传概率估计.
结论:
- 癌症遗传性在不同种族之间表现出显著的差异.
- 这项研究强调了种族背景在癌症遗传研究中的重要性.
- 结果为癌症遗传学和遗传咨询策略提供了有价值的数据.
更多相关视频
05:58Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
Published on: August 20, 2018
10.9K
11:20Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology
Published on: March 21, 2018
10.9K
相关概念视频
Heritability
198
Heritability is a statistical concept that measures the degree to which genetic differences among individuals contribute to trait variations within a population. It is a fundamental idea in genetics, often prone to misinterpretation. Heritability is expressed as a percentage, reflecting the proportion of variation in a specific trait across a population that can be linked to genetic differences. However, it's important to understand that heritability does not determine how "genetic"...
198
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Statistical Methods for Analyzing Epidemiological Data
363
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
363
Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K
Kaplan-Meier Approach
133
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
133
